ANGLE plc

Research ANGLE plc (DWV) on Bullrun: market cap EUR 33.10M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerDWV
• ExchangeF
• CountryUnited Kingdom
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyEUR
• Market capEUR 33.10M
• Financial periodFY2024
• RevenueEUR 2.86M
• Revenue growth30.9%
• Net income-EUR 14.23M
• Free cash flow-EUR 13.89M
• Gross margin62.2%

Valuation Snapshot

latest market cap is EUR 33.10M.

About ANGLE plc

CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis; and Parsortix PR1 system captures and harvests circulating tumour cells from blood.

Frequently asked questions

What is ANGLE plc's market cap?

ANGLE plc's market capitalization is EUR 33.10M.

What does ANGLE plc do?

CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally.